Related Experiment Video
Updated: Mar 12, 2026

08:37
A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
Published on: April 30, 2018
8.2K
Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase
Cinzia Cinesi1, Lorène Aeschbach1, Bin Yang1
1Center for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland.
Nature Communications
|November 10, 2016
Summary
Scientists discovered a new method to contract CAG/CTG repeats, which are linked to neurological diseases. This CRISPR-Cas9 nickase approach shows promise for developing treatments by reducing harmful repeat expansions in vivo.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- CAG/CTG repeat expansions are associated with over 13 incurable neurological diseases.
- Disease severity correlates with repeat tract length, suggesting repeat contraction as a therapeutic strategy.
Purpose of the Study:
- To investigate methods for specifically inducing CAG/CTG repeat contractions.
- To understand the mechanisms underlying repeat instability and contraction.
Main Methods:
- Utilized a GFP-based chromosomal reporter to monitor repeat expansions and contractions.
- Employed CRISPR-Cas9 D10A nickase to induce targeted DNA damage within repeat tracts.
- Investigated the roles of DNA damage response kinases (ATM, ATR) and repair proteins (MSH2, XPA).
Main Results:
- Inducing double-strand breaks caused instability in both expansion and contraction directions.
- CRISPR-Cas9 D10A nickase primarily induced contractions, independent of single-strand break repair.
- Nickase-induced contractions were dependent on the ATM kinase.
- ATR inhibition, in a MSH2- and XPA-dependent manner, increased both expansions and contractions.
Conclusions:
- DNA gaps within repeat tracts promote contractions.
- The type of DNA damage dictates the direction and extent of CAG/CTG repeat instability.
- This study provides a foundation for inducing CAG/CTG repeat contractions in vivo for therapeutic purposes.
Related Concept Videos
CRISPR
58.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.6K
CRISPR
18.7K
18.7K
CRISPR/Cas9 Genome Editing
2.4K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.4K
Homologous Recombination
64.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.9K
Conservative Site-specific Recombination and Phase Variation
7.2K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
7.2K
CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K

